Alnylam RNAi Technology definition

Alnylam RNAi Technology means, collectively, Alnylam RNAi Know-How and Alnylam RNAi Patent Rights.
Sample 1Sample 2Sample 3
Alnylam RNAi Technology means any and all technology, information, material, and know-how, including but not limited to inventions (including without limitation ALNYLAM Collaboration Inventions and ALNYLAM's rights in Joint Collaboration Inventions), discoveries, improvements, processes, methods, protocols, formulas, data, and trade secrets patentable or otherwise, which: (a) as of the Effective Date and/or during the Collaboration Term, is in the Control of ALNYLAM or its Affiliates, including without limitation, all technology, information, and material, including inventions, discoveries and know-how, patentable or otherwise, of ALNYLAM's scientific advisors and consultants which are Controlled by ALNYLAM or its Affiliates, and (b) is necessary or useful to MERCK for the Collaboration and/or for in vitro and/or in vivo target identification and/or target validation and/or for the research, development, manufacturing, marketing, use, import or sale of Therapeutic Collaboration Products within the Therapeutic Collaboration in the Territory including, but not limited to, knowledge related to (i) the RNAi pathway and mechanism of action in mammalian cells, (ii) informatics approaches to optimal siRNA design for targeting specific genes and minimizing off-target effects, (iii) optimal RNA chemistry for siRNA in vivo stability and delivery, (iv) bio-analytical methods for measurement of pharmacokinetics and biodistribution of siRNAs, and (v) RNAi delivery methods.
Sample 1Sample 2
Alnylam RNAi Technology means any and all Know-How (including without limitation ALNYLAM Collaboration Inventions), which: (a) as of the Original Effective Date and/or during the Collaboration Term, is in the Control of ALNYLAM or its Affiliates, including without limitation, all Know-How of ALNYLAM's scientific advisors and consultants which is Controlled by ALNYLAM or its Affiliates, and (b) is necessary or useful to MERCK for in vitro and/or in vivo target identification and/or target validation and/or for the Development, Manufacture or Commercialization of RNAi Therapeutic Products within the Therapeutic Collaboration, including, but not limited to, knowledge related to (i) the RNAi pathway and mechanism of action in mammalian cells, (ii) informatics approaches to optimal siRNA design for targeting specific genes and minimizing off-target effects, (iii) optimal RNA chemistry for siRNA in vivo stability and delivery, (iv) bio-analytical methods for measurement of pharmacokinetics and biodistribution of siRNAs, and (v) RNAi delivery methods.
Sample 1

Examples of Alnylam RNAi Technology in a sentence

  • Alnylam has the sole responsibility to, at Alnylam’s discretion, file, prosecute, conduct ex parte and inter partes proceedings (including the defense of any interference or opposition proceedings) and maintain, in the Territory, all Patent Rights comprising Alnylam RNAi Technology, Alnylam IOC Technology or Alnylam Collaboration IP, in Alnylam’s name.

  • Alnylam shall pay [**] of all royalties, license fees, milestones and similar payments (if any) payable to Alnylam’s Affiliates or to any Third Parties for the rights to Alnylam RNAi Technology, Alnylam IOC Technology and Alnylam Lipidoid Patent Rights licensed to Tekmira under this Agreement; [**].

  • About Alnylam RNAi Technology Tekmira has licenses to Alnylam RNAi intellectual property for certain siRNA programs.

  • For example, there are students who use tā’ maftūhah for the word تبر as تبر and alif lām as لو which should be attended by لا.Conclusion and Recommendation: Significantly, the research on students‟ answer scripts from translation section provides some information that can assist in the teaching of Arabic language communication.


More Definitions of Alnylam RNAi Technology

Alnylam RNAi Technology means, generally, Know-How which is Controlled by Alnylam or its Affiliates and is necessary or useful to Merck for in-vitro and/or in vivo target identification and/or target validation and/or for the Development, Manufacture or Commercialization of RNAi Therapeutic Products within the Therapeutic Collaboration, including, but not limited to, knowledge related to (i) RNAi pathway and mechanism of action in mammalian cells, (ii) informatics approaches to optimal siRNA design for targeting specific genes and minimizing off-target effects, (iii) optimal RNA chemistry for siRNA in vivo stability and delivery, (iv) bio-analytical methods for measurement of pharmacokinetics and biodistribution of siRNAs, and (v) RNAi delivery methods.
Sample 1

Related to Alnylam RNAi Technology

  • Program Technology means Program Know-How and Program Patents.

  • Licensor Technology means the Licensor Patents, the Licensor Know-How, Licensor Materials, and Non-Patent Rights Controlled by Licensor or its Affiliates embodied in Licensor Know-How or Licensor Materials.

  • Background Technology means all Software, data, know-how, ideas, methodologies, specifications, and other technology in which Contractor owns such Intellectual Property Rights as are necessary for Contractor to grant the rights and licenses set forth in Section 14.1, and for the State (including its licensees, successors and assigns) to exercise such rights and licenses, without violating any right of any Third Party or any Law or incurring any payment obligation to any Third Party. Background Technology must: (a) be identified as Background Technology in the Statement of Work; and (b) have been developed or otherwise acquired by Contractor prior to the date of the Statement of Work, or have been developed by Contractor outside of its performance under the Statement of Work. Background Technology will also include any general consulting tool or methodology created by Contractor, which will not be required to be identified in the Statement of Work.

  • Collaboration IP means the Collaboration Know-How and the Collaboration Patents.

  • Company Technology means all Technology used in or necessary for the conduct of the business of the Company or any of its Subsidiaries, or owned or held for use by the Company or any of its Subsidiaries.

  • Licensed Technology means the Licensed Patents and the Licensed Know-How.

  • Collaboration Patents means any and all Patents that claim or cover any of the Collaboration Know-How.

  • Patent Rights means all patents and patent applications, including all divisionals, continuations, substitutions, continuations-in-part, re-examinations, reissues, additions, renewals, extensions, registrations, and supplemental protection certificates and the like of any of the foregoing.

  • Developed IP means any Intellectual Property Rights that are conceived or reduced to practice, or otherwise created or developed, by or on behalf of a Party, its Affiliates or sublicensees, alone or together with one or more Third Parties, during the Term in connection with the Development, Manufacture, or use of the Compound or any Product.

  • Licensed Patent Rights means: (a) Patent applications (including provisional patent applications and PCT patent applications) or patents listed in Appendix A, all divisions and continuations of these applications, all patents issuing from these applications, divisions, and continuations, and any reissues, reexaminations, and extensions of these patents; (b) to the extent that the following contain one or more claims directed to the invention or inventions disclosed in 2.9(a): (i) continuations-in-part of 2.9(a); (ii) all divisions and continuations of these continuations-in-part; (iii) all patents issuing from these continuations-in-part, divisions, and continuations; (iv) priority patent application(s) of 2.9(a); and (v) any reissues, reexaminations, and extensions of these patents; (c) to the extent that the following contain one or more claims directed to the invention or inventions disclosed in 2.9(a): all counterpart foreign and U.S. patent applications and patents to 2.9(a) and 2.9(b), including those listed in Appendix A; and (d) Licensed Patent Rights shall not include 2.9(b) or 2.9(c) to the extent that they contain one or more claims directed to new matter which is not the subject matter disclosed in 2.9(a).

  • Foreground IP means IP and IP Rights conceived, developed or created by, for or with Seller either alone or with third parties, in the performance of this Contract, including modifications to any Buyer Specification suggested by Seller.